No Financial Advisor. Except as set forth on Section 2.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 2 contracts
Sources: Merger Agreement (Targacept Inc), Merger Agreement (Zalicus Inc.)
No Financial Advisor. Except as set forth on Section 2.25 2.24 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 2 contracts
Sources: Merger Agreement (Emmaus Life Sciences, Inc.), Merger Agreement (MYnd Analytics, Inc.)
No Financial Advisor. Except as set forth on Section 2.25 Part 3.22 of the Company Tranzyme Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Tranzyme or any Subsidiary of the CompanyTranzyme.
Appears in 1 contract
Sources: Merger Agreement (Tranzyme Inc)
No Financial Advisor. Except as set forth on in Section 2.25 2.22 of the Company ▇▇▇▇▇’s Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company ▇▇▇▇▇’s or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 in Part 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Company, Merger Sub or any Subsidiary of the CompanyCompany Subsidiaries.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 2.19 of the Company Marker Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the CompanyMarker.
Appears in 1 contract
Sources: Merger Agreement (Tapimmune Inc.)
No Financial Advisor. Except as set forth on Section 2.25 in Part 2.22 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 Part 2.19 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger Transaction or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Sources: Share Purchase Agreement (Carbylan Therapeutics, Inc.)
No Financial Advisor. Except for as set forth on Section 2.25 2.22 of the Company VIA Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company VIA or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 Part 2.22 of the Company Buyer Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Buyer or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 Part 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of Holdings, the Company or any Subsidiary of the Companytheir Subsidiaries.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 Part 2.23 of the Company Merger Partner Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Merger Partner or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Sources: Merger Agreement (Novacea Inc)
No Financial Advisor. Except as set forth on Section 2.25 2.8 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Sources: Merger Agreement (Skinvisible Inc)
No Financial Advisor. Except as set forth on Section 2.25 2.26 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Sources: Merger Agreement (Second Sight Medical Products Inc)
No Financial Advisor. Except as set forth on Section 2.25 Part 2.21 of the Company Buyer Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Buyer or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Sources: Merger Agreement (Lpath, Inc)
No Financial Advisor. Except as set forth on in Section 2.25 3.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Sources: Business Combination Agreement (KBL Merger Corp. Iv)
No Financial Advisor. Except as set forth on Section 2.25 2.23 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Sources: Merger Agreement (Telik Inc)
No Financial Advisor. Except as set forth on Section 2.25 Schedule 2.22 of the Company Disclosure ScheduleLetter, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 2.23 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the CompanyGroup Companies.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 in Part 3.8 of the Company ONCE Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s 's fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger Share Exchange or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company ONCE or any Subsidiary of the CompanyISI.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 Part 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
Sources: Merger Agreement (Tranzyme Inc)
No Financial Advisor. Except as set forth on in Section 2.25 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company or any Subsidiary of the Company.
Appears in 1 contract
No Financial Advisor. Except as set forth on Section 2.25 Part 3.19 of the Company Lpath Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of the Company Lpath or any Subsidiary of the Companyits Subsidiaries.
Appears in 1 contract
Sources: Merger Agreement (Lpath, Inc)